A/Prof Philip Thompson
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
43 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
NGS-based measurable residual disease in long-term progression-free CLL survivors following FCR therapy.
DOI: 10.1182/bloodadvances.20260202432026
Journal article
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma
DOI: 10.1182/bloodadvances.20250166462026
Journal article
Ibrutinib with venetoclax in patients with relapsed/refractory chronic lymphocytic leukemia: A phase II study.
DOI: 10.1158/2643-3230.BCD-25-03452026
Journal article
Balancing gains and pains: infections in the bispecific era
DOI: 10.1080/10428194.2025.25860822025
Journal article
Epcoritamab combinations demonstrate promising efficacy in patients (pts) with Richter transformation (RT): First results from arms 2B (epcor lenalidomide [LEN]) and 2C (epcor R-CHOP) of the phase 1b/2 EPCORE CLL-1 trial
DOI: 10.1182/blood-2025-10152025
Journal article
Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era
DOI: 10.1002/ajh.277602024
Journal article
Impact of Prior Bendamustine Exposure on Bispecific Antibody Treatment Outcomes in Patients with Relapsed/Refractory Follicular Lymphoma
DOI: 10.1182/blood-2024-205671
RECENT SCHOLARLY WORKS
2024
Journal article
Bridging Radiotherapy to Axicabtagene Ciloleucel (axi-cel) Is Associated with Favourable Outcomes for Large B-Cell Lymphoma (LBCL) in Third-Line and Beyond: An Australian Single-Centre Real-World Experience
DOI: 10.1182/blood-2024-2097672024
Journal article
Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study
DOI: 10.1016/S2352-3026(24)00172-82024
Journal article
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions
DOI: 10.1182/blood.2023023388